Fuyuhiko Motoi

Yamagata University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Cancer Biology Cancer Biology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (9)

Hiroshi Oshio

Assistant Professor, M.D.,ph.D.

Yamagata University Hospital

JAPAN

View details

Hyeong Seok Kim

Seoul National University College of Medicine

SOUTH KOREA

View details

Kei Nakagawa

Tohoku Medical and Pharmaceutical University

JAPAN

View details

Takanori Morikawa

Associate Professor

Tohoku University Hospital

JAPAN

View details

Shinichi Fukushige

Tohoku University

JAPAN

View details

Takaaki Ikeda

Yamagata University

JAPAN

View details

Akira Horii

Professor Emeritus

Tohoku University

JAPAN

View details

Yoshiyuki Ueno

Professor and Chiarman

Yamagata University Faculty of Medicine

JAPAN

View details

Alex Blair

Assistant Professor of Surgery

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Fuyuhiko Motoi

Research Interests

Explore related searches

Contact this professor

Articles (14)

Treatment Outcomes in Patients Receiving Carbon-Ion Radiotherapy Versus Hepatectomy for Hepatocellular Carcinoma (≥4 cm): A Retrospective Study in Japan

ASO Visual Abstract: Favorable Response Defined by CA19-9 Reduction After Neoadjuvant Treatment for Pancreatic Cancer

ASO Author Reflections: How to Evaluate CA19-9 Response to Neoadjuvant Treatment for Resectable Pancreatic Cancer?: Reduced Value or Reduction Rate?

Favorable Response Defined by CA19-9 Reduction After Neoadjuvant Treatment for Pancreatic Cancer

TWIST1 is a prognostic factor for neoadjuvant chemotherapy for patients with resectable pancreatic cancer: a preliminary study

Effects of the different periods and magnitude of COVID‐19 infection spread on cancer operations: Interrupted time series analysis of medical claims data

Prognostic impact of postoperative circulating tumor DNA as a molecular minimal residual disease marker in patients with pancreatic cancer undergoing surgical resection

Learning curve of robotic rectal surgery using risk-adjusted cumulative summation: a 5-year institutional experience

Negative prognostic impact of sarcopenia before and after neoadjuvant chemotherapy for pancreatic cancer

Development, validation, and comparison of a nomogram based on radiologic findings for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: An international multicenter study

Serine/Threonine Kinase 11 Plays a Canonical Role in Malignant Progression of KRAS -Mutant and GNAS -Wild-Type Intraductal Papillary Mucinous Neoplasms of the Pancreas

Levels of tumor markers CEA/CA 19–9 in serum and peritoneal lavage predict postoperative recurrence in patients with pancreatic cancer

Potential urinary function benefits of initial robotic surgery for rectal cancer in the introductory phase

Collaborators (9)

Hiroshi Oshio

Hyeong Seok Kim

Kei Nakagawa

Takanori Morikawa

Shinichi Fukushige

Takaaki Ikeda

Akira Horii

Yoshiyuki Ueno

Alex Blair

Make your next move.